Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

NCT01530620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Neurogenic Urinary Bladder Disorder
Urinary Bladder, Neurogenic
Bladder Disorder, Neurogenic
Urinary Bladder Disorder, Neurogenic
Neurogenic Bladder Disorder
Urinary Bladder Neurogenic Dysfunction
Urologic Diseases
Overactive Detrusor Function
Urinary Incontinence

Interventions

DRUG: Propiverine hydrochloride ER (extended release)
DRUG: Propiverine hydrochloride IR (immediate release)

Sponsor

APOGEPHA Arzneimittel GmbH